Multiplexed microfluidic platform for stem-cell derived pancreatic islet β cells.
Multiplexed microfluidic platform for stem-cell derived pancreatic islet β cells.
复制标题
DOI:
10.1039/d2lc00468b
复制
发表时间:
2022-11-08
期刊:
影响因子:
6.1
通讯作者:
Healy, Kevin E.
中科院分区:
文献类型:
--
作者:
Goswami, Ishan;de Klerk, Eleonora;Carnese, Phichitpol;Hebrok, Matthias;Healy, Kevin E.
Stem cell-derived β cells offer an alternative to primary islets for biomedical discoveries as well as a potential surrogate for islet transplantation. The expense and challenge of obtaining and maintaining functional stem cell-derived β cells calls for a need to develop better high-content and high-throughput culture systems. Microphysiological systems (MPS) are promising high-content in vitro platforms, but scaling for high-throughput screening and discoveries remain a challenge. Traditionally, simultaneous multiplexing of liquid handling and cell loading poses a challenge in the design of high-throughput MPS. Furthermore, although MPS for islet β culture/testing have been developed, studies on multi-day culture of stem-cell derived β cells in MPS have been limited. We present a scalable, multiplexed islet β MPS device that incorporates microfluidic gradient generators to parallelize fluid handling for culture and test conditions. We demonstrated the viability and functionality of the stem cell-derived enriched β clusters (eBCs) for a week, as assessed by the ∼2 fold insulin release by the clusters to glucose challenge. To show the scalable multiplexing for drug testing, we demonstrated the loss of stimulation index after long-term exposure to logarithmic concentration range of glybenclamide. The MPS cultured eBCs also confirmed a glycolytic bottleneck as inferred by insulin secretion responses to metabolites methyl succinate and glyceric acid. Thus, we present an innovative culture platform for eBCs with a balance of high-content and high-throughput characteristics. Multiplexed microphysiological system as a high-content, higher throughput device for stem cell-derived β cell culture and drug screening.
登录
查看更多内容
影响因子:
16.6
作者:
Millman JR;Xie C;Van Dervort A;Gürtler M;Pagliuca FW;Melton DA
通讯作者:
Melton DA
影响因子:
7.4
作者:
Dishinger, John F.;Reid, Kendra R.;Kennedy, Robert T.
通讯作者:
Kennedy, Robert T.
影响因子:
4.6
作者:
Ionescu-Tirgoviste C;Gagniuc PA;Gubceac E;Mardare L;Popescu I;Dima S;Militaru M
通讯作者:
Militaru M
影响因子:
5.2
作者:
de Klerk E;Hebrok M
通讯作者:
Hebrok M
DOI:
10.1038/s41574-021-00568-0
发表时间:
2022-01
期刊:
Nature reviews. Endocrinology
影响因子:
--
作者:
Benninger RKP;Kravets V
通讯作者:
Kravets V